NeuroThera Labs Announces Share Consolidation
NeuroThera Labs (NTLX:CA), a subsidiary of SciSparc, has announced that it will consolidate its common shares on a 1-for-14 basis. The consolidation is expected to take effect at market open around September 2, 2026. Following the consolidation, NTLX's stock will begin trading based on the new share structure. The move aims to adjust the company’s capital structure and potentially improve its financial metrics for investors. Share consolidations are often used by companies with low stock prices to increase per-share value without altering market capitalization.
Topics: capital changes stock structure